ATF-Long 20 mg, #40



Indications and usage:

ATF-Long is used as part of complex therapy in the following cases:

– CAD;

– Exertional stenocardia and resting stenocardia;

– Unstable stenocardia;

– Myocardial cardiosclerosis and postinfarction cardiosclerosis (local and diffuse);

– Supra-ventricular tachycardia, paroxysmal tachycardia;

– Myocardiodystrophy;

– Vegetovascular dystonia;

– Myocarditis;

– Other heart rhythm disorders.

ATF-Long is used in hyperuricemia of various origin, chronic fatigue syndrome, as well as in order to improve tolerance towards physical activities.

Dosage and administrations:

10-40 mg 3-4 times a day. Average treatment duration is 20-30 days. Retreatment course in 10-15 days may be given.

Treatment of arrhythmia and acute cardiological conditions: single dose (10-40 mg) is administered in 10 minutes after acute symptomatology reversal. Maximum daily dose is 400-600 mg.

Adverse effects: occasionally – nausea, abdominal pain and sense of discomfort, allergic reactions. In case of long-term and uncontrolled administration – hypermagnesaemia  and hyperkalemia.


ATF-Long is contraindicated in patients with acute myocardial infarction, hypermagnesaemia  and hyperkalemia, severe forms of bronchial asthma, haemorrhagic stroke, AV blockade of II-III stage, hypersensitivity to drug components. ATF-Long is not used in pregnant and breast-feeding women.

Pregnancy and lactation period: there is no information on safety and efficacy of ATF-Long administration in pregnant women. Breast-feeding women should not use ATF-Long.

Overdosage: symptoms: brachycardia, arterial hypotension and atrio-ventricular block.

Treatment: in case of the following side effects the medication should be immediately withdrawn. In case of brachycardia the injection of atropine sulfate is needed.


There are no reviews yet.

Be the first to review “ATF-Long 20 mg, #40”

Your email address will not be published. Required fields are marked *